Drug discovery company that combines artificial intelligence and neuroscience.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Verge Genomics operates as a drug discovery company that combines artificial intelligence and neuroscience expertise to find new drugs that would dramatically improve the lives of patients suffering from neurodegenerative disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Verge Genomics Management Team
Investors
Eli Lilly & Company
Vulcan Capital
OS Fund
Draper Fisher Jurvetson (DFJ)
IA Ventures
Threshold Ventures
Karlin Ventures
BlackRock Inc
Merck Global Health Innovation Fund
LifeForce Capital
Slow Ventures
Great Oaks Venture Capital
Agent Capital
WuXi AppTec
Tao Capital Partners
Section 32
ALS Investment Fund
Two Sigma
Verge Genomics Valuations & Financials
View real-time NPM data on Verge Genomics stock including daily Verge Genomics stock price estimates, valuation history, and historical share price information. Access Verge Genomics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Verge Genomics pricing across six independent market signals. Looking for private company due diligence data sources on Verge Genomics? Get in touch to learn more.
Similar Companies
like Verge Genomics
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Neuron23
Healthcare & Life Sciences
Biotechnology company focused on developing personalized medicines for genetic disorders.
Click Therapeutics
Biotechnology company that develops, validates, and commercializes software as prescription medical treatments
FAQ
We have answers
Verge Genomics stock does not trade on public stock exchanges. Verge Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Verge Genomics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Verge Genomics Stock does not trade on public stock exchanges. In order to sell Verge Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Verge Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Verge Genomics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Verge Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Verge Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Verge Genomics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Verge Genomics is a private company and has not had an IPO. There is currently no Verge Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Verge Genomics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
